Assessment of ADRB1 polymorphism in patients with acute coronary syndrome treated with ticagrelor and aspirin

References

• Malakar AK, Choudhury D, Halder B et al. A review on coronary artery disease, its risk factors, and therapeutics. J. Cell. Physiol. 234(10), 16812–16823 (2019).
   PubMed Web of Science ®Google Scholar
• Zhang H, Merkus D, Zhang P et al. Predicting protective gene biomarker of acute coronary syndrome by the circRNA-associated competitive endogenous RNA regulatory network. Front. Genet. 13, 1030510 (2022).
   PubMed Web of Science ®Google Scholar
• Dong P, Yang X, Bian S. Genetic polymorphism of CYP2C19 and inhibitory effects of ticagrelor and clopidogrel towards post-percutaneous coronary intervention (PCI) platelet aggregation in patients with acute coronary syndromes. Med. Sci. Monit. 22, 4929–4936 (2016).
   PubMed Web of Science ®Google Scholar
• Jin C, Torii R, Ramasamy A et al. Morphological and physiological characteristics of ruptured plaques in native arteries and neoatherosclerotic segments: an OCT-based and computational fluid dynamics study. Front. Cardiovasc. Med. 9, 890799 (2022).
   PubMed Web of Science ®Google Scholar
• Xu WJ, Wang S, Yuan P et al. Arterial and venous thromboembolism risk associated with blood eosinophils: a systematic review and meta-analysis. Animal Models Exp. Med. 5(5), 470–481 (2022).
   PubMedGoogle Scholar
• Dong Z, Zhai H, Pan L, Zhang B. Stronger inhibitory effects of ticagrelor plus aspirin compared with clopidogrel plus aspirin on arachidonic acid-induced platelet aggregation in patients with acute coronary syndrome with PCI. J. Pak. Med. Assoc. 71(2(a)), 540–542 (2021).
   PubMed Web of Science ®Google Scholar
• Yang B, Zheng C, Yu H et al. Comparison of efficacy between clopidogrel and ticagrelor in patients with acute coronary syndrome after interventional treatment and their effects on IL-6. Iran. J. Public Health 49(2), 240–248 (2020).
   PubMed Web of Science ®Google Scholar
• Yang C, Ren J, Li B et al. Identification of gene biomarkers in patients with postmenopausal osteoporosis. Mol. Med. Rep. 19(2), 1065–1073 (2019).
   PubMed Web of Science ®Google Scholar
• Kolovou G, Kolovou V, Mavrogeni S. β-Adrenergic receptor gene polymorphisms and its relationship with heart failure. Curr. Vasc. Pharmacol. 16(6), 624 (2018).
   PubMed Web of Science ®Google Scholar
• Tai J, Zou J, Zhang X et al. Using network pharmacology to explore potential treatment mechanism for coronary heart disease using Chuanxiong and Jiangxiang essential oils in Jingzhi Guanxin prescriptions. Evid. Based Complement. Alternat. Med. 2019, 7631365 (2019).
   PubMed Web of Science ®Google Scholar
• El-Menyar A, Rizk NM, Asim M et al. Association of β-adrenergic receptor gene polymorphisms with acute coronary syndrome and cardiovascular risk factors in an Arab population. Angiology 67(8), 762–771 (2016).
   PubMed Web of Science ®Google Scholar
• Lindkvist M, Fernberg U, Ljungberg LU et al. Individual variations in platelet reactivity towards ADP, epinephrine, collagen and nitric oxide, and the association to arterial function in young, healthy adults. Thromb. Res. 174, 5–12 (2019).
   PubMed Web of Science ®Google Scholar
• Traby L, Kollars M, Kaider A et al. Differential effects of ticagrelor with or without aspirin on platelet reactivity and coagulation activation: a randomized trial in healthy volunteers. Clin. Pharmacol. Ther. 107(2), 415–422 (2020).
   PubMed Web of Science ®Google Scholar
• Dziedzic EA, Gąsior JS, Tuzimek A et al. No association of hair zinc concentration with coronary artery disease severity and no relation with acute coronary syndromes. Biomolecules 12(7), 862 (2022).
   PubMed Web of Science ®Google Scholar
• Guo M, Xia C, Wu Y et al. Research progress on cell membrane-coated biomimetic delivery systems. Front. Bioeng. Biotechnol. 9, 772522 (2021).
   PubMed Web of Science ®Google Scholar
• Dandamudi A, Akbar H, Cancelas J, Zheng Y. Rho GTPase signaling in platelet regulation and implication for antiplatelet therapies. Int. J.Mol. Sci. 24(3), 2519 (2023).
   PubMed Web of Science ®Google Scholar
• De Winter RJ. Treating patients suffering from acute coronary syndrome with prasugrel, the Rotterdam experience. Neth. Heart J. 26(7–8), 365–366 (2018).
   PubMed Web of Science ®Google Scholar
• Patrono C, Rocca B. Aspirin at 120: retiring, recombining, or repurposing? Res. Pract. Throm. Haemost. 5(4), e12516 (2021).
   PubMed Web of Science ®Google Scholar
• Qiu X, Li X, Fu K et al. The effect of ticagrelor on coronary microvascular function after PCI in patients with ACS compared to clopidogrel: a systematic review and meta-analysis. PlOS One 18(8), e0289243 (2023).
   PubMed Web of Science ®Google Scholar
• Wu B, Shi L. Cost-utility of ticagrelor plus aspirin in diabetic patients with stable coronary artery disease. Eur. Heart J. 7(6), 529–538 (2021).
   Web of Science ®Google Scholar
• Sibbing D, Aradi D, Alexopoulos D et al. Updated expert consensus statement on platelet function and genetic testing for guiding P2Y(12) receptor inhibitor treatment in percutaneous coronary intervention. JACC. Cardiovasc. Interv. 12(16), 1521–1537 (2019).
   PubMed Web of Science ®Google Scholar
• El-Khodary NM, El-Behery AM, El-Askary NA et al. The correlation between platelet responsiveness to clopidogrel and CYP2C19 polymorphism in patients with peripheral vascular disease. Eur. Rev. Med. Pharmacol. Sci. 25(19), 6065–6076 (2021).
   PubMed Web of Science ®Google Scholar
• Liedes H, Pajula J, Vuorinen AL et al. CYP3A4*22 may increase bleeding risk in ticagrelor users. Basic Clin. Pharmacol. Toxicol. 133(2), 202–207 (2023).
   PubMed Web of Science ®Google Scholar
• Chaudhary PK, Kim S, Jee Y et al. Role of GRK6 in the regulation of platelet activation through selective G protein-coupled receptor (GPCR) desensitization. Int. J. Mol. Sci. 21(11), 3932 (2020).
   PubMed Web of Science ®Google Scholar
• Cortés-Martín A, Colmenarejo G, Selma MV, Espín JC. Genetic polymorphisms, Mediterranean diet and microbiota-associated urolithin metabotypes can predict obesity in childhood-adolescence. Sci. Rep. 10(1), 7850 (2020).
   PubMed Web of Science ®Google Scholar
• Fayed MS, Saleh MA, Sabri NA, Elkholy AA. β1-adrenergic receptor polymorphisms: a possible genetic predictor of bisoprolol response in acute coronary syndrome. Future Sci. OA 9(10), Fso895 (2023).
   PubMed Web of Science ®Google Scholar
• Matuskova L, Czippelova B, Turianikova Z et al. Beta-adrenergic receptors gene polymorphisms are associated with cardiac contractility and blood pressure variability. Physiol. Res. 70(S3), S327–s337 (2021).
   PubMedGoogle Scholar